9 /100
LOW RISK
Score updated Jul 13, 2026

NTES — NetEase, Inc. Dilution Risk Tracker

Track NTES dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NTES — Get alerts when the score changes →

As of July 13, 2026, NetEase, Inc. (NTES) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. NetEase, Inc. has a market capitalization of $78.69B, 3.19B shares outstanding. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NTES.
🔔 Track NTES — Get forecast alerts →

💹 Market Data

Market Cap$78.69B
Shares Outstanding3.19B
FloatN/A
Cash$10.01B
Debt$58.63M
Short InterestN/A

🏛 Institutional Holdings

9.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track NTES for full holder detail →

📉 Short Interest

Short Interest2.60M
Days to Cover2.4
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2008
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NTES Shareholders

NetEase, Inc. (NTES) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for NTES shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NTES in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NTES alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NTES Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NTES — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NTES
📊 NTES FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NTES Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.